Your browser is no longer supported. Please, upgrade your browser.
Settings
VIRS [AMEX]
Pacer BioThreat Strategy ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week3.22%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-0.18%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter2.71%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y11.30%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year16.93%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range26.67 - 34.61 Perf YTD20.66%
Dividend0.26 P/FCF- EPS past 5Y- ROI- 52W High-2.60% Beta-
Dividend %0.77% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low26.41% ATR0.27
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)61.89 Volatility0.21% 0.25%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.00 Prev Close33.71
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume1.34K Price33.71
Recom- SMA203.19% SMA500.80% SMA2008.72% Volume1 Change0.00%
Aug-25-21 12:00PM  
The investment seeks to track the performance, before fees and expenses, of the LifeSci BioThreat Strategy Index (the "index"). Under normal circumstances, at least 80% of the fundas total assets (exclusive of collateral held from securities lending) will be invested in the component securities of the index. The index is generally composed of U.S.-listed stocks of companies whose products or services help protect against, endure, or recover from biological threats to human health. It is non-diversified.